Cord blood-based neonatal genetic screening for thalassemia in Guiyang, China (2015): a cross-sectional study.

Neonatal cord blood screening in Guiyang, China, found a 7.4% thalassemia carrier rate, with α-thalassemia being most common among 1,000 neonates.

• Why it matters: Understanding the prevalence and genetic spectrum of thalassemia in multi-ethnic regions like Guiyang addresses a gap in population-level screening data, aiding targeted public health strategies.
• What they did: Researchers conducted genetic screening using commercial kits on 1,000 full-term neonates' cord blood samples, with high-throughput sequencing for those with abnormal blood tests or family history.
• The result: The study identified specific prevalent mutations and revealed significantly higher carrier rates in minority groups such as Buyi, Dong, and Tujia, highlighting the need for focused epidemiological follow-up.